Pharmaceutical Isolator Market Overview
Pharmaceutical and biotech companies utilize pharmaceutical isolators extensively to prevent contamination during the production process. These machines work in accordance with the latest safety guidelines laid down by regulatory bodies. Regulatory compliance to maintain high sterility level in pharmaceutical products is a key factor driving the global pharmaceutical isolator market. High-potency active pharmaceutical ingredients (APIs) such as cytostatic, hormones, and antibiotics are prepared under very strict safety parameters where pharmaceutical isolators are ideally suited. They are progressively replacing traditional clean-rooms as they provide greater sterility assurance. This factor can take the global pharmaceutical isolators market ahead.
The global Pharmaceutical Isolator Market stood at USD 20,876.4 Mnand is estimated to attain a valuation of 32,944.3 Mn by the end of 2027. Pharmaceutical isolators are intended to provide absolute separation between the operator and end product to save the operator from the hazards associated with potent product handling. They also aid in the alleviation of risk of cross-contamination and to enhance the standard of drug. Pharmaceutical isolators are of utmost importance in the pharmaceutical industry, and the global pharmaceutical isolator market is likely to post a CAGR of 7.86% over the forecast period , asserts Market Research Future (MRFR) in an in-depth study.
On the other hand, the market is at threat from the availability and preference for Restricted Access Barrier Systems (RABS) used for aseptic processing which can constrain the growth of the market. However, technological improvements in pharmaceutical isolators are viewed as an opportunity for further market progress.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/4683
Pharmaceutical Isolator Market Segmentation
The global pharmaceutical isolator market has been segmented based on type, pressure, application, and end user.
By type, the global pharmaceutical isolator market has been segmented into closed and open isolator. The open isolator segment is the dominant segment which accounts for 60.5% share of the global market. The open isolator segment can reach a valuation of USD 20,566.3 Mn at a CAGR of 8.56% over the forecast period.
By pressure, the global pharmaceutical isolator market has been segmented into positive and negative pressure. The positive pressure segment is the largest segment and holds almost 55.5% share of the market. The positive pressure segment is expected to advance with a CAGR of 8.42% while the negative pressure segment is expected to register a CAGR of 7.15% over the forecast period.
By application, the global pharmaceutical isolator market has been segmented into aseptic filling, fluid dispensing, sampling/weighing/distribution, product containment, and others. The aseptic filling segment is domineering the global market and can expect a CAGR of 8.37% while the fluid sampling segment is expected to attain the highest CAGR of 9.92% over the forecast period.
By end user, the global pharmaceutical isolator market has been segmented into pharmaceutical and biotechnological companies, hospitals, research academic laboratories, and others. The pharmaceutical and biotechnological companies account for almost 45.8% share of the global market and are expected to expand at a CAGR of 8.13% over the forecast period. The research academic laboratories segment is expected to capture the highest CAGR of 9.17% over the forecast period.
Pharmaceutical Isolator Market Regional Analysis
By region, the global pharmaceutical isolator market has been segmented into the Americas, Europe, Asia Pacific (APAC), and the Middle East and Africa (MEA).
The Americas is at the forefront of the global pharmaceutical isolator market and is likely to maintain its lead over the forecast period. The pharmaceutical industry in the region is a frontrunner in the adoption of the latest technologies which foster market growth. The Americas market is likely to expand at a CAGR of 8.08% and reach USD 12,142.2 Mn by the end of 2023.
Europe is the second largest market for pharmaceutical isolators. The presence of a high number of research and academic institutes in the region who deploy pharmaceutical isolators boost the growth of the market. Europe market is estimated to grow with a CAGR of 7.31% over the forecast period.
APAC is the fastest growing market for pharmaceutical isolators and is expected to capture the highest CAGR of 8.73% over the forecast period. However, the MEA market is expected to exhibit sluggish growth and could reach USD 1,398.5 Mn by 2023.
Pharmaceutical Isolator Market Players
- AzbilTelstarSkanAGGetinge AB
- VanRxPharmasystems Inc.
- Schematic Engineering Industries
- NuAire Inc.
- Robert Bosch GmbH
- MBRAUN
- FedegariAutoclaviSpA
- Hosokawa Micron Ltd
- IsoTech Design
- COMECER SpA cf. p.iva
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/pharmaceutical-isolator-market-4683
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: sales@marketresearchfuture.com
